Rudolf M Huber

Author PubWeight™ 51.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011 21.49
2 Combined transcriptome and genome analysis of single micrometastatic cells. Nat Biotechnol 2002 2.48
3 MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. Am J Respir Cell Mol Biol 2004 1.87
4 Detection of melanoma antigen-A expression in sputum and bronchial lavage fluid of patients with lung cancer. Chest 2004 1.46
5 Topotecan/cisplatin compared with cisplatin/etoposide as first-line treatment for patients with extensive disease small-cell lung cancer: final results of a randomized phase III trial. J Thorac Oncol 2012 1.45
6 Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 2012 1.28
7 Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med 2004 1.05
8 Telomere length in circulating leukocytes is associated with lung function and disease. Eur Respir J 2013 1.04
9 Direct medical costs of COPD--an excess cost approach based on two population-based studies. Respir Med 2011 0.95
10 Influence of air pressure, humidity, solar radiation, temperature, and wind speed on ambulatory visits due to chronic obstructive pulmonary disease in Bavaria, Germany. Int J Biometeorol 2011 0.91
11 Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany. Oncol Res Treat 2014 0.90
12 IL-13Ralpha2 reverses the effects of IL-13 and IL-4 on bronchial reactivity and acetylcholine-induced Ca+ signaling. Int Arch Allergy Immunol 2006 0.90
13 Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma. Am J Respir Med 2003 0.85
14 Pulmonary function in patients with type 1 diabetes before and after simultaneous pancreas and kidney transplantation. Transplantation 2007 0.84
15 The use of mini-organ cultures of human upper aerodigestive tract epithelia in ecogenotoxicology. Mutat Res 2004 0.83
16 Endoplasmic reticulum Ca2+-homeostasis is altered in Small and non-small Cell Lung Cancer cell lines. J Exp Clin Cancer Res 2009 0.83
17 Ca2+-signaling in airway smooth muscle cells is altered in T-bet knock-out mice. Respir Res 2006 0.83
18 Lung diffusing capacity for nitric oxide and carbon monoxide: dependence on breath-hold time. Chest 2008 0.82
19 Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC. Diagn Pathol 2014 0.82
20 High blood pressure, antihypertensive medication and lung function in a general adult population. Respir Res 2011 0.81
21 In-vivo kinetics of inhaled 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in bronchial tissue. Respir Res 2007 0.81
22 Spirometric reference values for advanced age from a South german population. Respiration 2012 0.81
23 Acute effects of hemodialysis on lung function in patients with end-stage renal disease. Wien Klin Wochenschr 2006 0.81
24 Reference values of impulse oscillometric lung function indices in adults of advanced age. PLoS One 2013 0.81
25 Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors. Radiat Oncol 2013 0.81
26 Thoracic Oncology HERMES syllabus: setting the basis for thoracic oncology training in Europe. Eur Respir J 2013 0.81
27 Toxic epidermal necrolysis after pemetrexed and cisplatin for non-small cell lung cancer in a patient with sharp syndrome. Onkologie 2012 0.80
28 Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis. BMC Pulm Med 2009 0.80
29 Topotecan therapy in patients with relapsed small-cell lung cancer and poor performance status. Clin Lung Cancer 2006 0.80
30 Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study. Onkologie 2006 0.79
31 Smoking cessation in lung cancer-achievable and effective. Dtsch Arztebl Int 2013 0.79
32 Independent information of nonspecific biomarkers in exhaled breath condensate. Respiration 2010 0.78
33 Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosis. J Mol Med (Berl) 2014 0.76
34 Exhaled nitric oxide and influencing factors in a random population sample. Respir Med 2010 0.76
35 Is lung cancer in never-smokers a different disease?--Back to the figures. J Thorac Oncol 2007 0.75
36 [Current developments and perspectives in targeted therapies]. Onkologie 2010 0.75
37 [Clinic for Radiation Therapy and Internal Medicine Oncology, Pius-Hospital Oldenburg, Germany]. Onkologie 2011 0.75
38 [Structures and ways of decision making in thoracic oncology: foreword]. Onkologie 2013 0.75
39 [Concept of quality assurance in the management of lung carcinoma]. Onkologie 2006 0.75
40 [Geriatric assessment and diagnosis in elderly patients]. Onkologie 2008 0.75
41 [Foreword]. Onkologie 2008 0.75
42 [Thoracic oncology - optimization through integrated approaches, quality assurance, and molecular biology. Forward]. Onkologie 2012 0.75
43 [Pillnitz interdisciplinary discussion--summary]. Onkologie 2006 0.75
44 [Local and systemic therapy of non-small cell lung carcinoma (NSCLC)]. Onkologie 2010 0.75
45 [Therapy for non-small-cell lung carcinoma (NSCLC) in stage IV]. Onkologie 2006 0.75
46 Cystic fibrosis diagnosed in a 38-year-old man with long-standing HIV infection. Clin Infect Dis 2004 0.75
47 Cancer vaccination causes prolonged FDG accumulation in subcutaneous tissue. Nuklearmedizin 2017 0.75
48 [Tumor conference II]. Onkologie 2013 0.75
49 [Quality assurance]. Onkologie 2012 0.75